Renaissance Technologies LLC Raises Its Investment in Chemours Company (The) (CC)

Financial Architects Inc increased its stake in shares of Chemours Company (The) by 1,230.3% in the second quarter. They now have a "buy" rating on the stock. Ropes Wealth Advisors LLC boosted its position in shares of Chemours Company (The) by 82.4% in the first quarter.

As of quarter end Twin Tree Management, Lp had sold a total of 25,300 shares trimming its stake by 15.2%. The stock has relative volume of 1.46.

7/13/2017 - Chemours Company (The) had its "buy" rating reaffirmed by analysts at Jefferies Group LLC.

6/16/2017 - Chemours Company (The) had its "buy" rating reaffirmed by analysts at Jefferies Group LLC. Hedge funds and other institutional investors own 75.21% of the company's stock.

The Chemours Company (CC) has the market capitalization of $8.56 Billion. These ratios are important while doing valuation of the company or the shares of the company. The firm's 50 day moving average price is $43.25 and its 200-day moving average price is $37.90. Dimensional Fund Advisors increased its position in stocks of Chemours Company (The) by 51.6% in the Q4. The value of the company's investment in Chemours Company (The) went from $32,357,000 to $30,669,000 decreasing 5.2% for the reporting period. Accern also assigned news headlines about the specialty chemicals company an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. Chemours Company (The) had a return on equity of 122.97% and a net margin of 4.96%. The business had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.49 billion. The company's 5 year Earnings per share growth and Capital Spending growth remains at -65.59 and -0.98. Chemours Company (The)'s revenue for the quarter was up 14.8% compared to the same quarter previous year. Analysts anticipate that Chemours Company will post $3.55 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 15th. This dividend represents a yield of $0.24. The ex-dividend date has been established as Monday the 15th of May 2017. The dividend payment will be $0.030 per share for the quarter or $0.12 on an annualized basis.

ILLEGAL ACTIVITY WARNING: This piece was reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another domain, it was stolen and republished in violation of global copyright & trademark legislation. "Takes Position in Chemours Company (The) (NYSE:CC)" was first published by Sports Perspectives and is the property of of Sports Perspectives.

CC has been the subject of several other research reports.

UBS raised the price target and upgraded the stock on August 7 boosting the price target from $16.00 to $50.00 and altering the rating from "Neutral" to "Neutral". Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The company showed volatility of 5.34% over the past week and moving out to look at the previous month volatility move, the stock is at 3.45%.

7/5/2017 - Chemours Company (The) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.

Many analysts have provided their estimated foresights on The Chemours Company Earnings, with 7 analysts believing the company would generate an Average Estimate of $1.02. Chemours Company (The) has an average rating of "Buy" and an average target price of $46.25.

In related news, insider Paul Kirsch sold 19,036 shares of the firm's stock in a transaction dated Monday, June 5th. The stock was unloaded at a price range of of $41.42, amounting to $788,471.12. company executives has an ownership of 1.14% of the firms stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Erich Parker sold 4,908 shares of the business's stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $45.53, for a total value of $223,461.24. The disclosure for this sale can be found here.

The Chemours Company, launched on February 18, 2014, is a provider of performance chemicals. It operating segment consists of Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide. Fluoroproducts segment provides fluoroproducts, refrigerants and industrial fluoropolymer resins.

Like this



27 March 2018
The Growth of Online Gaming and Betting Companies
Even though brick and mortar casinos make offers to gamblers, they do not come anywhere close to what is offered on the wide web. Alternatively, they can be used to learn about the game and the features it comes with as well as the strategies that work best.

12 August 2017
Miller-Uibo bounces back to ease into 200m final
Already a bronze medallist in the 1500m, Caster Semenya is looking strong over her favoured distance of 800m. But defending champion Danielle Williams of Jamaica is out after a poor start and hitting five hurdles.

12 August 2017
Synchrony Financial (SYF) Stake Up in Latest Report from Tcw Group Inc
The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink . The Company's revenue activities are managed through three sales platforms: Retail Card, Payment Solutions and CareCredit.

12 August 2017
Endo International PLC (NASDAQ:ENDP) Earns "Hold" Rating from BMO Capital Markets
The short sellers will then buy the stock back at a much lower price and replace the borrowed shares, pocketing the difference. Oppenheimer Holdings, Inc. reaffirmed a hold rating on shares of Endo International PLC in a report on Thursday, June 8th.

12 August 2017
How Does Eastman Chemical Company (EMN) Stack Up Right Now?
It improved, as 53 investors sold DOW shares while 333 reduced holdings. 78 funds opened positions while 188 raised stakes. Dow Chemical Company (The) presently has a average recommendation of "Buy" and an average price target of $71.42.

12 August 2017
Proshare Advisors LLC Increases Its Stake in PPG Industries, Inc. (PPG)
PPG Industries , Inc manufactures and distributes a range of coatings and specialty materials. (NYSE:PPG) or 19,947 shares. Eight equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company.

12 August 2017
Needle Moving Activity Spotted in Starbucks Corporation (NASDAQ:SBUX)
The company's shares were given away at $60.63 per share worth to an income of some $606,300 on account of ULLMAN MYRON E III . The Missouri-based Paradigm Finance Advisors Limited Liability has invested 0.33% in Starbucks Corporation (NASDAQ:SBUX).

12 August 2017
Why Manchester City are favorites to win the Premier League
We will change one important player, it depends on who we are going to stay. It's completely the same, because it's the same manager.

12 August 2017
Nationwide profits drop by a fifth
The buy-to-let market has also been hit by the 3% increase in stamp duty on second homes and changes to mortgage tax relief. That gives Nationwide a 13 per cent gross share of the United Kingdom mortgage market, according to Mr Garner's statement.

12 August 2017
Over 50 Lingayat seers meet CM, demand separate religion tag
Some prominent seers, including those of Suttur Mutt and Siddaganga Mutt, however, were not present at the meeting. However, amongst the separatists, infighting arose regarding the difference between Veerashaivas and Lingayats.